Silgard

human papillomavirus type 6 L1 protein; human papillomavirus type 11 L1 protein; human papillomavirus type 16 L1 protein; human papillomavirus type 18 L1 protein · Merck Sharp & Dohme Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Silgard, covering 2019-04-02 to 2019-04-02. Get the full timeline:

Most recent: EMA Withdrawn: Silgard (human papillomavirus type 6 L1 protein;human papillomavirus type 11 L1 protein;human papillomavirus type 16 L1 protein;human papillomavirus type 18 L1 protein) — Merck Sharp Dohme Ltd

See pricing